Morning Rounds: The ‘very risky business’ of buying weight loss drugs online
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Author: STAT
FDA ad comm favors Zevra’s Niemann-Pick drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections
WASHINGTON — Medicare officials are offering private insurers big subsidies to keep premiums for prescription-drug…
Politics is holding back the best tool for treating meth addiction
When it comes to treating methamphetamine addiction, the use of behavioral incentives is settled science….
Opinion: Diversity statements should not be required for federal STEMM grant funding
Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel…
.jpg)
Opinion: Phasing out the ‘D-word’
As I roamed the meeting rooms and halls of the Alzheimer’s Association International Conference in…
Opinion: Performance-enhancing drugs or placebos? The myth at the heart of anti-doping
With Chinese swimmers getting 200 drug tests over 10 days ahead of the Paris Olympics,…
Opinion: Letters on Sonya Massey’s death, vaccine injuries, and much more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
Weight loss drugs without a prescription? Study warns it’s a “very risky business”
In the face of ongoing shortages of the obesity and diabetes medications known as GLP-1s,…
.jpg)
Opinion: The coronavirus lab leak hypothesis is damaging science
Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 —…
STAT+: Pharmalittle: We’re reading about a soft-tissue cancer drug approval, the Zepbound shortage ending, and more
Good morning, and happy Friday. This is Jonathan Wosen, West Coast biotech and life sciences…
STAT+: 23andMe board rejects co-founder Anne Wojcicki’s offer to take company private
A special committee of the board of directors of 23andMe rejected an offer from the…
Moderna is still in a Covid hangover
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Trump gave patients a ‘right to try.’ It hasn’t helped them
As Donald Trump seeks a second presidential term, front and center among the achievements he’s…
STAT+: UnitedHealth and HCA clash over hospital chain’s rates in ‘battle of the giants’
Contract disputes between hospitals and health plans have become routine, but they tend to be…
Opinion: ACL tears in women: Too many injuries and too little research
Some of the world’s finest athletes were sidelined by a torn anterior cruciate ligament (the…
What we do and don’t know about the shortage of blood culture bottles
In July, federal health officials warned hospitals that there would be a critical shortage of…
Opinion: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
The promise of scientific and medical innovation often comes with a downside: improvements in care…
STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer
LONDON — U.S. regulators have authorized a cutting-edge treatment relying on T cells for a…
STAT+: Private equity firms to acquire health care billing and payments firm R1 in $8.9 billion deal
R1 RCM is finally getting taken off the public markets, ending a months-long saga between…
Listen: The long journey to make malaria vaccines, and Sarepta’s ties with patient advocates
Why has it taken so long for the world to get malaria vaccines? What relationship…
Morning Rounds: Inside the making of the first malaria vaccine
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: On Andrew Left and the government’s fraud case
I love the Summer Olympics. Every four years I transform into a huge fan of…
Opinion: Make caregiving a defining issue of the 2024 election
Kamala Harris, the current vice president and now Democratic candidate for president, made a bold…
STAT+: Jim Wilson, gene therapy pioneer, departs Penn to set up new companies
Jim Wilson, a leading gene therapy researcher who has persisted through the field’s ups and…
venBio raises $528 million for its fifth fund
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re watching positive Zepbound cardiovascular data, a move to take 23andMe private, and more
Greetings from London, with STAT reporter Andrew Joseph here filling in for Ed for the…
STAT+: With new data, RegenxBio advances plan for Duchenne gene therapy
Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy was administered to…
STAT+: Eli Lilly’s obesity drug Zepbound shows benefits in heart failure patients
Eli Lilly’s obesity drug Zepbound cut the risk of complications and improved symptoms in patients…
4 takeaways from STAT’s story on the development of malaria vaccines
For the first time, the world is starting to roll out malaria vaccines to children…
Opinion: Rising rates of skin cancer: The cost of FDA’s inaction on novel sunscreen products
A decade after Sen. Jack Reed (D-R.I.) authored the Sunscreen Innovation Act, which became law…
Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers
Malaria is one of our most ancient foes — and one of the wiliest. Caused…
Opinion: PBMs aren’t opening access to lower-cost biosimilars. Reform is needed now
The Federal Trade Commission presents on Thursday its interim staff report, “Pharmacy Benefit Managers: The Powerful…
With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot
In President Biden’s address to the nation after dropping out of the election race, he…
The health care records of 5 leading candidates to be Harris’ VP
WASHINGTON — With less than 100 days until the presidential election, Democratic candidate Kamala Harris is…
STAT+: 23andMe co-founder Anne Wojcicki files to take company private
A trust controlled by 23andMe co-founder Anne Wojcicki has formally filed to take the genetic…
Morning Rounds: Grindr gets into health care lobbying
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Vision loss and high cholesterol identified as risk factors for dementia
Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable…
The debate over how long to use Alzheimer’s drugs
Good morning. We have a new investigation out today about how Mount Sinai in New…
STAT+: Pharmalittle: We’re watching GLP-1 drug data in Alzheimer’s, a flu shot push for livestock workers, and more
Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I…
What I learned about ultra-processed foods from stuffing my face at the world’s leading food technology event
CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne…
STAT+: Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes…
Opinion: DNA data security requires robust protections, not rhetoric
The BIOSECURE Act, now rolling through Congress, aims to protect the DNA data of Americans…
Biden administration should push for addiction medication in recovery houses, groups say
The Biden administration isn’t doing enough to ensure people living in recovery housing have access…
Opinion: Cost counseling and stewardship need to be part of medical school curricula
In my third week as a medical intern, I learned a vital lesson about the…
STAT+: 7 key people who could shape Trump’s health care policy
WASHINGTON — A second Trump administration would bring a new wave of health policy officials…
STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs
Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by…
STAT+: Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data
Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for…
STAT+: NIH loses suit over censoring social media comments made by animal rights advocates
In a boost for animal rights advocates, a U.S. appeals court ruled that a National…
Substance use stayed at high levels in 2023, while vaping increased and smoking fell
Rates of mental illness and substance use remained largely stable in 2023, according to federal…